TWC 2024 | 7th Theranostics World Congress

Welcome to the Theranostics World Congress 2024 retrospective! We invite you to journey back and explore the key moments, insightful presentations, and remarkable advancements showcased during TWC 2024. Join us as we reflect on the latest breakthroughs in Theranostics and revisit the spirit of collaboration and innovation that defines our congress. Enjoy your exploration!

    Information

    Congress date

    March 22–24, 2024

    Congress venue

    W SANTIAGO
    Isidora Goyenechea 3000, Las Condes
    Santiago, Chile

    Congress language

    The congress language is English

    Congress chairs
    Congress President

    Prof. Dr. Horacio Amaral Pineda
    Santiago, Chile

    Congress President

    Dr. Vasko Kramer
    Santiago, Chile

    Co-Congress President

    Prof. Dr. Frank Rösch
    Berlin, Germany

    Co-Congress President

    Prof. Dr. Richard P. Baum
    Wiesbaden, Germany

    Welcome Message

    Dear colleagues and friends,

    On behalf of the scientific board and organizing committee, it is our pleasure to extend a warm welcome and invite you to join us for the 7th Theranostic World Congress (TWC) that will be held from 22nd to 24th of March 2024 in the beautiful city of Santiago, Chile.

    The TWC is an international conference that brings together leading experts in the field from around the world. Our goal is to provide a platform for researchers, students, clinicians, and industry professionals to share their knowledge, learn and discuss the latest advancements in this exciting field.

    Maintain the same spirit and format, the 7th TWC program will cover a wide range of topics with dedicated sessions on prostate cancer, neuroendocrine tumors, targeting tumor microenvironment, new radioisotopes and their production, novel radiochemistry and chelators, combination therapies, patient access, and many others. We also encourage you to send us topic-related abstracts about your research to be shared either as poster or oral presentation.

    We are also excited to announce a one-day pre-conference event for professionals from South America with the aim of extending access to Theranostics and increasing awareness. This event will provide radiochemists, nuclear medicine physicians and other healthcare professionals with the opportunity to learn more about the practical aspects of this emerging field.

    We are confident that you will have an unforgettable experience attending the TWC in Santiago.

    We are looking forward to seeing you in Santiago and to productive discussions and collaborations that will help advance the field and ultimately benefit patients worldwide.

    Yours sincerely,

    Horacio Amaral

    Vasko Kramer

    Richard Baum

    Frank Rösch

    Scientific Comittee

    Alonso, Omar (Centro Uruguayo de Imágenes Moleculares , Uruguay)

    Avila Rodriguez, Miguel (UNAM, Ciudad de Mexico, Mexico)

    Barboza, Marycel (Nuclear Medicine, Hospital Albert Einstein, Sao Paolo, Brasil)

    Bastianello, Maria (Universidad de Buenos Aires, CEMIC, Argentina)

    Buchpiguel, Carlos (Department of Radiology, University of Sao Paolo; Hospital Sirio Libanes, Brasil)

    Casale, Guillermo (Laboratorio Bacon, Buenos Aires, Argentina)

    Echtebehere, Elba (Nuclear Medicine, University of Campinas, Brasil)

    Faccio, Fernando (Departamento de Imágenes Sanatorio San Gerónimo, Argentina)

    Fernandez, Rene (Positronmed, Chile)

    Granador, Carlos (Hospital Universitario San Ignaci, Colombia)

    Huapaya, Danfer (Clinica Anglo Americana, Lima, Peru)

    Lopez, Rafael (Sociedade Brasileira de Medicina Nuclear, Brasil)

    Matushita, Cristina (Pontificia Universidad Catolica de Rio Grande do Sul, Brasil)

    Olarte Casas, Miguel Angel (UNAM, Ciudad de Mexico, Mexico)

    Perfecto Oliva, Juan (CENTIS, Cuba)

    Racioppi, Silvina (Head of Nuclear Medicine Theranostics, IO Alex Fleming, Argentina)

    Rey, Ana (Área Radioquímica, Facultad de Química, Universidad de la República, Uruguay)

    Rodriguez, Jose Luis (Clinica Las Condes, Chile)

    Savio, Eduardo (Centro Uruguayo de Imágenes Moleculares , Uruguay)

    Program

    A comprehensive overview of the sessions, speakers, and topics that fueled discussions and drove innovation during our congress. Dive into the program to rediscover the wealth of knowledge shared by experts in the field of Theranostics.

    Main Topics

    • Patient Access & Healthcare System Readiness
    • Prostate Cancer
    • NET & other Cancers
    • Medical Physics & Instrumentation
    • Novel Targets, Chemistry, Indications
    • Updates on Radioisotope Production
    • Tumor Microenvironment
    • Combination Therapies
    • Industry Symposia & Exposition

    ... and much more

    Program Overview

    PreCongress

    Thursday, 21st of March

    8:30 – 8:45

    Opening Remarks

    8:45 – 10:00

    ICPO Academy

    10:30 – 11:30

    LATAM Symposium on Radiochemistry

    11:30 – 12:30

    LATAM Symposium on Medical Physics & Instrumentation

    15:00 – 16:00

    LATAM Symposium on Nuclear Medicine

    16:00 – 17:00

    LATAM Symposium on Patient Access, Regulation & Coverage

    19:30 – 0:00

    SPEAKERS WELCOME

    TWC Congress

    Friday, 22nd of March

    8:30 – 10:00

    Opening Ceremony & Opening Lecture

    10:30 – 11:15

    Patient Access Session – Panel Discussion of ICPO/Oncidium

    11:15 – 12:00

    Healthcare System Readiness for RLT – Panel Discussion

    13:30 – 15:00

    Neuroendocrine Tumors & others

    15:30 – 17:00

    Prostate Cancer

    17:00 – 17:30

    ProstTIC24 Recap

    17:30 – 18:30

    Poster Session

    19:30 – 0:00

    SOCIAL EVENING - VISTA SANTIAGO (including transport to event)

    Saturday, 23rd of March

    8:30 – 10:00

    Medical Physics & Instrumentation

    10:45 – 11:45

    Industry Session I
    3B Pharmaceuticals GmbH
    FAP: Therapy, Imaging, and Beyond

    12:15 – 12:45

    Industry Session II
    Novartis
    How Partnerships can support innovation & evolution of RLT in the future

    13:00 – 13:30

    Industry Session III
    ITM Isotope Technologies Munich SE
    Emitting Excellence: Illuminating the evolving landscape of Radiopharmaceutical Therapy

    13:30 – 15:00

    Novel Targets & Chemistry Session

    15:30 – 16:30

    TME Diagnostics

    16:30 – 18:00

    TME Therapeutics

    18:00 – 18:20

    TME – Panel Discussion

    Sunday, 24th of March

    8:15 – 9:15

    Current State of Isotope Production

    10:30 – 11:15

    Industry Session IV
    Siemens Healthineers

    11:45 – 12:30

    Industry Session V
    Joint Symposium
    211At industrials within the World Astatine Community (WAC)

    12:45 – 13:05

    Industry Session VI
    GE Healthcare International LLC
    Building the future in theranostics

    13:30 – 15:00

    Novel Indication, Concepts & Genetics

    15:30 – 17:00

    Combination Therapies

    17:00 – 17:30

    Closing Ceremony

    last updated: March 19, 2024

    Invited Speakers

    Abarca, Lorena (MINSAL, Chile)

    Avila Rodriguez, Miguel (Autonomus University of Mexico, Mexico)

    Babich, John (Ratio Therapeutics, USA)

    Bachmann, Michael (FZ Dresden-Rossendorf, Germany)

    Bal, Chandrasekhar (AIIMS, New Delhi, India)

    Ballal, Sanjana (AIIMS, New Delhi, India)

    Barbosa, Nataly (CTIC, Colombia)

    Baum, Richard P. (Curanosticum, ICPO, Germany)

    Bednarz, Bryan P. (Univ. Wisconsin, USA)

    Beyer, Thomas (University Vienna, Austria)

    Buchpiguel, Carlos (Hospital Sirio Libanes, Brasil)

    Chen, Shawn (LNC, Singapore)

    Cherry, Simon (UC Davis, USA)

    Constanzo, Julie (INSERM, Montpellier, France)

    Cutler, Cathy (Brookhaven National Laboratory, USA)

    Delpassand, Ebrahim (RadioMedix / Excel Diagnostics, USA)

    Eiber, Matthias (Technische Universität München, Germany)

    Etchebehere, Elba (University of Campinas, Brasil)

    Evans, Paul (GEHC, USA)

    Flamen, Patrick (Hôpital Universitaire de Bruxelles, Belgium)

    Gagnon, Katherine (GE Healthcare, Schweden)

    Geshani, Munir (Mount Sinai, USA)

    Gestin, Jean-Francois (COST, NOAR, France)

    Giesel, Frederik (Heinrich Heine University Düsseldorf, Germany)

    Goic, Carolina (PUCCH, Chile)

    Gourni, Eleni (Inselspital Bern, Switzerland, Switzerland)

    Greifenstein, Lukas (Curanosticum, Germany)

    Günter, Thomas (UCSF Stanford, USA)

    Herth, Matthias (University of Copenhagen, Denmark)

    Hicks, Rodney (University of Melbourne and Monash University, Australia)

    Hofman, Michael (PeterMac, Australia)

    Huerta, Luis (Cchen, Chile)

    Iagaru, Andrei (Stanford, USA)

    Jeong, Jae Min (Seoul National University, South Korea)

    Kjaer, Andreas (University of Copenhagen, Denmark)+

    Korde, Aruna (IAEA, Austria)

    Kossatz, Susanne (TU Munich, Germany)

    Krause, Bernd (University Hospital Rostock, Germany)

    Kulkarni, Harshad (BAMF, USA)

    Kunikowska, Jolanta (Nuclear Medicine Department, Medical University of Warsaw, Poland)

    Lapi, Suzanne (University of Alabama, USA)

    Lewis, Jason (MSKCC, USA)

    Maharaj, Masha (WARMTH, South Africa)

    Mailman, Josh (Norcal, USA)

    Martin, Marcel (TetraKit Technologies, Denmark)

    Martin, Sergio (ALMA Observatory, Chile)

    Matushita, Christina (SBMN, Brasil)

    Mena Cortes, Danny (Hospital Angeles Lomas, Mexico)

    Mock, Jacqueline (Philochem, Switzerland)

    Mossesian, Sherly (Sofie Bioscience, USA)

    Nadel, Helen (Stanford, USA)

    Paganelli, Giovanni (European Institute of Oncology, Italy)

    Perfecto Oliva, Juan (CENTIS, Cuba)

    Pouget, Jean Pierre (INSERM, Montpellier, France)

    Prasad, Vikas (Mallinkrodt Institute of Radiology, USA)

    Radchenko, Valery (Triumf, University of British Columbia, Canada)

    Racioppi, Silvia (Oncologic Institute Alex Fleming, Argentina)

    Rey, Ana (Área Radioquímica, Facultad de Química, Universidad de la República, Uruguay)

    Rösch, Frank (Johannes Gutenberg University Mainz, Germany)

    Sarduy, Eduardo Aluicio (Wisconsin Cyclotron Lab, USA)

    Sartor, Oliver (Mayo Clinic, USA)

    Sathekge, Mike (University of Pretoria, South Africa)

    Schultz, Michael (Perspective Therapeutics, USA)

    Scott, Andrew (Olivia Newton John Cancer Research Institute, Australia)

    Shi, Kuangyu (University of Bern, Switzerland)

    Simecek, Jakub (Trimt, Germany)

    Singh, Baljinder (PGIMER, Chandigarh, India)

    van der Veken, Pieter (University of Antwerp, Belgium)

    Watabe, Tadashi (Osaka University, Japan)

    Weber, Wolfgang (TU Munich, Germany)

    Werner, Rudolf (Frankfurt University Hospital, Germany)

    Wirtz, Ralph (Stratifyer, Germany)

    Zan, Elcin (Weil Cornell University, USA)

    Zhang, Jingjing (University of Singapore, Singapore)

    Relive the Brilliance of TWC2024!

    We extend our heartfelt gratitude to our esteemed sponsors, whose steadfast support was instrumental in making the Theranostics World Congress a resounding success. Dive into the invaluable contributions they made to advance medical science and reshape healthcare. Let's reminisce on the inspiring moments of TWC2024 and continue our journey towards transformative breakthroughs together!

    Abstracts

    In 2024 abstracts could be submitted for one of the following topics. The best abstracts were honored with the poster awards.

    Abstract Topics
    1. Prostate Cancer: Focuses on innovative approaches to diagnose, treat, and manage prostate cancer, including advancements in imaging techniques, targeted therapies, and personalized medicine approaches.

    2. Neuroendocrine Tumors: Presents research on the diagnosis and treatment of neuroendocrine tumors, with a focus on theranostic applications for identifying and targeting these rare cancers.

    3. Novel Targets & Chemistry: Showcases novel molecular targets and innovative chemical compounds for theranostic applications in cancer treatment, with an emphasis on improving specificity and efficacy.

    4. Tumor Microenvironment:

      • Diagnostics: Presents novel techniques for characterizing the tumor microenvironment, such as advanced imaging modalities and biomarker analysis, to guide treatment decisions.

      • Therapeutics: Explores therapeutic strategies targeting the tumor microenvironment, including immunotherapies and stromal-targeted approaches, aimed at disrupting tumor growth and progression.

    5. Combination Therapies: Highlights research on the synergistic effects of combining different treatment modalities, such as chemotherapy, radiotherapy, and immunotherapy, to enhance therapeutic outcomes and overcome treatment resistance.

    6. Radioisotopes: Focuses on the use of radioisotopes in theranostic applications, including radiopharmaceuticals for imaging and targeted radionuclide therapy for cancer treatment.

    7. Medical Physics & Instrumentation: Presents advancements in medical physics and instrumentation technologies, including imaging devices, radiation therapy delivery systems, and dosimetry methods, to improve precision and accuracy in cancer diagnosis and treatment.

    8. Novel Indications, Genetics, Vaccinations: Explores emerging indications for theranostic approaches, such as rare cancers or specific genetic mutations, and investigates the potential of cancer vaccines in combination with theranostics for personalized treatment strategies.

    Explore the Interactive ePoster Book!

    Discover a comprehensive collection of ePosters showcased and discussed onsite at the event, now available for download in PDF format. Delve into the latest research and insights presented by leading experts in the field. Click below to download the ePoster book and explore the cutting-edge findings!

    Awards

    During the congress, awards were presented to recognize excellence in various fields. These awards honored the best abstracts, outstanding achievements in Theranostics, notable contributions to Nuclear Medicine, and remarkable accomplishments in radiopharmacy that are closely related to Theranostics.

    Poster Awards

    The best three submitted Abstracts in recognition of outstanding work in Radiomolecular Precision Medicine were honored as part of the 7th Theranostic World Congress (TWC).

    PSMA PET volume metrics estimated with artificial intelligence-based segmentation as predictor to 177Lu-iPSMA radioligand in patients with metastatic castrate resistant prostate cancer.

    Irma Soldevilla Gallardo
    Mexico City, Mexico

    Preliminary comparison of 68Ga-FAPI-46 against 18F-FDG, 68Ga-DOTATATE and 68Ga-Pentixafor PET/CT/MR imaging in the assessment of various cancer types.

    Habibollah Dadgar
    Mashhad, Iran

    Differences between α- and β-emitting targeted radiotherapy on the tumor microenvironment using single cell analysis in preclinical brain tumors.

    Sydney Jackson
    USA

    Edwaldo E. Camargo Young Investigator Award

    Dr. Edwaldo Eduardo Camargo was a highly accomplished scientist and pioneer in the field of Nuclear Medicine. Born in Brazil in 1938, he obtained his medical degree and pursued his passion for Nuclear Medicine through advanced studies at Johns Hopkins University. He made significant contributions to the field in Brazil, implementing Nuclear Cardiology, developing radioisotope preparation and distribution, and promoting education and residency programs. Dr. Camargo held leadership positions, published numerous papers, and was admired for his humility and dedication to teaching.

    The Edwaldo E. Camargo Young Investigator Award honors an individual who has made outstanding achievements in the field of Nuclear Medicine and which are related to Theranostics and was presented at the congress by Dr. Elcin Zan on March 22, 2024.

    Award Winner

    Dr. Sanjala Ballal
    Department of Nuclear Medicine at All India Institute of Medical Sciences, India

    Award Committee

    Dr. Elcin Zan
    Weil Cornell University, USA


    Amount

    3,000 US$

    Number of Awards

    one

    Award Period

    7th Theranostic World Congress, Santiago, 2024

    Sponsor

    CMR Brazil, CEO: Sibila Grallert

    Saul Hertz Young Investigator Award

    The Saul Hertz Young Investigator Award honors outstanding achievement and excellence of early-career professionals in the field of theranostics and was presented at the congress by Prof. Dr. Susanne Kossatz on March 22, 2024.

    Award Winner

    Prof. Dr. Simone Krebs
    Memorial Sloan Kettering Cancer Center, USA

    Award Committee

    Prof. Dr. Susanne Kossatz
    TUM School of Medicine and Health, Germany

    Amount

    5,000 EUR

    Number of Awards

    one

    Award Period

    biannually

    Sponsor

    Academy of the International Centers for Precision Oncology. President: Professor Dr. Richard P. Baum

    Jorge Nicolini Young Investigator Award

    Dr. Jorge Nicolini was a Biochemist from Buenos Aires, Argentina and a pioneer in the field of radiopharmacy. As co-founder of the Argentinian Society of Nuclear Medicine, of Laboratorios Bacon, and as a brilliant scientist and teacher he made outstanding contributions to the field during his active carrer of over 50 years.

    The Jorge Nicolini Young Investigator Award honors an individual who has made outstanding achievements in the field of radiopharmacy and which are related to Theranostics such as radiopharmaceutical development, isotope production, basic research, in-vitro and preclinical evaluation or translation of radiopharmaceuticals.

    The award was presented at the congress by Prof. Dr. Susanne Kossatz on March 22, 2024.

    Award Winner

    Dr. Sara Rinne
    Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, USA

    Award Committee

    Prof. Dr. Susanne Kossatz
    TUM School of Medicine and Health, Germany

    Amount

    3,000 US$

    Number of Awards

    one

    Award Period

    7th Theranostic World Congress, Santiago, 2024

    Sponsor

    Laboratorios Bacon SAIC